managing conflicts across multiple board seats: map conflicts before calendars fill

A declaration made separately to each company can miss the conflict created by the portfolio as a whole. Maintain a controlled inventory of boards, executive roles, advisory work, material investments, close relatives’ positions and significant professional-firm relationships. Add each organisation’s parent, subsidiaries, major joint ventures and known portfolio companies. Record dates and the nature of exposure, not only company names. A group that looked unrelated at appointment may become connected through acquisition, financing or a common customer months later. Include cessation dates because confidentiality and litigation exposure can continue after a formal office ends.

Map relationship categories across companies: competitor, customer, supplier, lender, investor, adviser, regulator, litigation counterparty, talent source and transaction prospect. Include opportunity conflicts where two boards may pursue the same asset, licence, executive or market. Different sectors do not guarantee separation; a bank, technology provider and retailer can share data, payments and vendor interests. The inventory should allow the director to identify overlap before agendas and papers reveal sensitive strategy. Add prospective transactions when known lawfully, using access controls that do not reveal one board’s strategy to another organisation.

Limit access to the portfolio map because it contains confidential relationship data from several organisations. Each company receives the facts it needs for its own analysis, while counsel or a designated personal governance record may preserve the full cross-portfolio view. Do not copy one board’s customer list into another board’s system. Use categories and seek advice where even naming the relationship would disclose protected information. The director’s personal adviser should follow explicit confidentiality and deletion terms rather than accumulating unrestricted copies of portfolio correspondence.

Recusal at the meeting can be too late if the director already received the paper, joined informal preparation or influenced the agenda. Establish pre-circulation screening with each company secretary. Agenda descriptions should be specific enough to flag a known overlap without exposing the restricted substance. When a possible issue appears, pause distribution, clarify the parties through an authorised route and decide access, attendance, voting and minutes treatment before information moves. A screening query should reveal only the minimum counterparty detail needed for the director to recognise and escalate the overlap.

Information barriers must work operationally. Use separate portals, devices or managed profiles; never forward papers between company or employer email accounts. Keep assistants outside restricted material unless their access is approved by the relevant company. Calendar entries should avoid strategic detail. Do not use insights from one board to ask suspiciously informed questions at another, even without quoting a document. Fiduciary judgement cannot be separated from the duty to protect how the underlying knowledge was acquired. Review mobile backups, printing and conferencing tools because a portal barrier alone does not control every copy or participant.

A manageable transactional conflict may require disclosure, exclusion from papers, absence from discussion and voting, and accurate minutes under current law and company policy. The remaining board must still have valid composition, quorum and expertise. A committee chair’s recusal can be more disruptive than an ordinary member’s, particularly during an investigation or related-party review. Plan who receives assurance and leads the agenda rather than improvising after the meeting begins. If the director leaves, document transfer of chair responsibilities and open actions without granting continuing access to restricted committee material.

A pervasive conflict may require resignation or refusal of the new seat. If two companies compete on core strategy, pursue the same customers or depend on information the director cannot compartmentalise, repeated recusal can make service ineffective. The test is not whether attendance can be preserved but whether the director can receive enough information and exercise judgement for each company. No confidentiality protocol turns structurally divided loyalty into useful independence. Measure the proportion of agenda repeatedly missed; high formal attendance can conceal that the director cannot contribute to core strategy.

Perceived conflict also deserves analysis. A relationship may fall outside a numerical threshold yet undermine stakeholder confidence, regulator comfort or independence of mind. Record the facts, advice, safeguards and rationale instead of dismissing perception as optics. Conversely, do not label every remote overlap disqualifying without proportional assessment. A well-governed response distinguishes legal interest, statutory independence, fiduciary conflict, information risk and reputation, because each can call for a different action. Where perception remains material, consider independent chair or investor input while protecting the confidentiality of the underlying relationship.

Section 184 interests, Section 166 duties, Section 149 independence and listed-entity requirements overlap but are not interchangeable. A disclosed interest may require board-process treatment without automatically answering independent status; a relationship affecting independence may exist before a specific transaction. Apply current Sections 149, 166, 184, 188 and relevant Rules, plus Regulations 16, 17, 23 and other LODR provisions where applicable. Sector fit-and-proper and connected-party rules may add stricter analysis. Obtain current advice on the actual entity, transaction and role because thresholds and sector classifications can change the required response.

Capacity deteriorates when recusals concentrate work on other directors. A portfolio may sit within Section 165 and LODR numerical limits yet become impractical because the same financial year, committee peaks or cross-company incidents collide. Track not only meetings attended but papers excluded, emergency calls, committee substitutions and actions delayed. Before adding a role, model one conflict at the same time as results or a regulatory event, and ask whether every affected board still has effective independent oversight. Model quorum after two simultaneous recusals, not only the more convenient assumption that every other director remains available.

Remuneration, advisory fees and investments can create both incentives and relationships. Keep compensation from each company transparent and approved, avoid side engagements that blur the non-executive role, and update shareholding or beneficial-interest records. A director should not trade in one company using knowledge inferred from another. Listed-company UPSI controls and trading-window procedures require company-specific handling, while the director’s cross-portfolio view calls for more cautious personal dealing where information boundaries are uncertain. Pre-clear personal trades conservatively when cross-company knowledge could make the source or materiality of an inference difficult to separate.

At onboarding, agree notification contacts, screening mechanics, document controls, recusal records and the route for independent legal advice. Give the company secretary enough relationship categories to protect distribution, and update immediately after a new client, investment, relative role, proposed transaction or board appointment. Annual declarations are a backstop, not the main detection method. Committee charters and board portals should support event-driven changes without exposing the underlying confidential fact more widely than necessary. Name an alternate secretarial contact for urgent matters so a holiday or absence does not allow restricted papers to circulate automatically.

When a conflict emerges, create a decision record covering the relationship, information already received, legal and policy analysis, proposed safeguard, decision-maker, duration and review event. Correct earlier access if possible, including return, deletion and restrictions on further discussion. Minutes should record disclosure and non-participation accurately without publishing unnecessary confidential detail. For a listed entity, assess exchange or related-party disclosures separately from the internal minute. The record should also identify whether the director influenced earlier work before recognising the conflict and what remediation followed.

Review the portfolio at least quarterly and before accepting another seat, major transaction, committee chair or executive appointment. Ask whether past recusals reveal a pattern, whether barriers have worked and whether any board receives materially reduced contribution. If the role is no longer serviceable, plan resignation and handover rather than waiting for a public dispute. This guidance is general: obtain qualified company, securities, competition, employment and sector advice for current facts and notifications. Include feedback from company secretaries on whether screening instructions remain usable as group structures and committee mandates evolve.